EVP and Head of R&D and Chief Medical Officer · Organon & Co. (OGN)

Juan Camilo Arjona Ferreira

A named executive officer of Organon in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$3,822,487

FY2024: $3,599,751

Compensation figures as of the proxy filed April 24, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-09-24.

Juan Camilo Arjona Ferreira compensation by year

Organon Summary Compensation Table · all 2 fiscal years held
In US dollars, as Organon reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$650,000$734,615
Bonus$0$0
Stock awards$1,665,534$1,892,658
Option awards$499,998$599,998
Non-equity incentive$696,800$437,760
Pension and deferred compensation$0$0
All other$87,419$157,456
Total$3,599,751$3,822,487

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Organon & Co. DEF 14A filed April 24, 2026, accession 0001193125-26-177411, and prior-year filings. Open the filing on EDGAR.

$3.6M
$3.8M
FY24
FY25
SalaryNon-equity incentiveStock awardsOption awardsAll other

Insider transactions since the last proxy

3 Form 4 lines since the FY2025 proxy (filed April 24, 2026)
current to 2026-09-24 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-08-11Exercise or conversion—11,519$0.0041,566.48
2026-08-11Tax withholding—4,134$13.6237,432.48
2026-08-11Exercise or conversion derivative—11,519$0.000

The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Organon’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Kevin AliFormer Chief Executive Officer$15,813,296
Joseph MorrisseyInterim Chief Executive Officer$5,772,848
Matthew WalshEVP and Chief Financial Officer$5,686,204
Juan Camilo Arjona Ferreira · this pageEVP and Head of R&D and Chief Medical Officer$3,822,487
Rachel StahlerEVP and Chief Digital & Growth Officer$3,551,619
Kirke WeaverEVP, General Counsel and Corporate Secretary$3,542,975

The full Organon compensation record

free company brief

This page is one person within Organon's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Organon's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Organon's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy